AGO Trademark

Trademark Overview


On Tuesday, December 7, 2021, a trademark application was filed for AGO with the United States Patent and Trademark Office. The USPTO has given the AGO trademark a serial number of 97159649. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, June 20, 2024. This trademark is owned by Nuecology Biomedical Inc.. The AGO trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Vaccine for human purposes; Anti-inflammatory agent; Anticancer agent; Medicines for the treatment of cancer; Active pharmaceutical ingredients, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Antiviral agent; Biological preparations for the treatment of cancer; Vaccines; Germicides; Cellulose esters for pharmaceutical purposes; Pharmaceutical preparations for suppressing tumors; Stem cells for medical purposes; Colloids, namely, alginates for pharmaceutical purposes

Synthetic polymer for use in the manufacture of delivery agents for pharmaceuticals; Colloids, namely, chemical gels for the manufacture of delivery agents for pharmaceuticals; Dendrimer-based polymers for use in the manufacture of capsules for pharmaceuticals; Polymers for use in the manufacture of medicines; Polymers for use in the manufacture of pharmaceutical coatings
ago

General Information


Serial Number97159649
Word MarkAGO
Filing DateTuesday, December 7, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, June 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements


Goods and ServicesVaccine for human purposes; Anti-inflammatory agent; Anticancer agent; Medicines for the treatment of cancer; Active pharmaceutical ingredients, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Antiviral agent; Biological preparations for the treatment of cancer; Vaccines; Germicides; Cellulose esters for pharmaceutical purposes; Pharmaceutical preparations for suppressing tumors; Stem cells for medical purposes; Colloids, namely, alginates for pharmaceutical purposes
Goods and ServicesSynthetic polymer for use in the manufacture of delivery agents for pharmaceuticals; Colloids, namely, chemical gels for the manufacture of delivery agents for pharmaceuticals; Dendrimer-based polymers for use in the manufacture of capsules for pharmaceuticals; Polymers for use in the manufacture of medicines; Polymers for use in the manufacture of pharmaceutical coatings

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, April 12, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNuecology Biomedical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRichmond, B.C. V6X3Z7
CA

Party NameNuecology Biomedical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRichmond, B.C. V6X3Z7
CA

Trademark Events


Event DateEvent Description
Friday, December 10, 2021NEW APPLICATION ENTERED
Monday, December 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 15, 2022ASSIGNED TO EXAMINER
Saturday, September 17, 2022NON-FINAL ACTION WRITTEN
Saturday, September 17, 2022NON-FINAL ACTION E-MAILED
Saturday, September 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 15, 2023FINAL REFUSAL WRITTEN
Wednesday, March 15, 2023FINAL REFUSAL E-MAILED
Wednesday, March 15, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 12, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 12, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, April 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 12, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, April 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 8, 2024SOU EXTENSION 1 GRANTED
Monday, January 8, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 8, 2024SOU EXTENSION 1 FILED
Thursday, June 20, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 20, 2024SOU EXTENSION 2 FILED
Thursday, June 20, 2024SOU EXTENSION 2 GRANTED
Wednesday, January 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED